701 Pennsylvania Avenue, NW Suite 200, Washington, DC USA 20004
Christopher Thomas advises clients on developing patent strategies tailored to meeting business goals and analyzing patent-related risks and opportunities. Chris focuses on advancing the business goals of clients in the United States and abroad by implementing strategies that position and protect his client’s business expansion and growth. His practice includes client counseling; efficiently managing, growing, and protecting worldwide patent portfolios; conducting IP due diligences to support investment and acquisitions; negotiating patent licenses; challenging/defending patents at the PTAB; and advising on patent litigation matters. Chris’ litigation experience relates to assisting with evaluating patent litigation risks from third-parties and developing strategies for mitigating those risks. His litigation experience also includes developing inter partes review (IPR) and post grant review (PGR) strategies in concert with concurrent litigation. His technical focus includes chemistry, chemical engineering, industrial chemicals, biotechnology, medical devices, material science, metallurgy, nanotechnology, mechanical devices, and consumer products.
Chris was recognized in 2024 and 2025 as one of the "Best Lawyers: Ones to Watch" for Intellectual Property Law by The Best Lawyers in America®. He was recognized as a Washington D.C. “Rising Star” in 2024 and the four years immediately preceding for Intellectual Property by Super Lawyers magazine. In 2022, Chris was named to the Capital Pro Bono Honor Roll, which recognizes the contributions of those D.C. Bar members who made significant contributions to pro bono service.
Prior to joining Kilpatrick, Chris served as a law clerk in the Office of Unfair Import Investigations of the U.S. International Trade Commission in Washington, D.C., where he assisted in Section 337 litigation for various IP issues. Before practicing law, Chris researched nanotechnology techniques for the design and manufacture of non-oxide nanoparticles for cancer treatment.
Insights View All
Blogs
Adversarial Patent Prosecution℠
Asset Creation - Prosecution & Counseling
Licensing, Transactions & Monetization
Apparel, Accessories & Luxury Goods
Chemicals: Industrial Chemistry & Materials and Material Science
Life Sciences: Biotechnology, Pharmaceuticals & Bioinformatics
University of New Hampshire School of Law J.D. (2014) with honors
State University of New York at Buffalo B.S. (2011) Chemical and Biological Engineering
District of Columbia (2018)
New York (2014)
U.S. Patent and Trademark Office (2014)
American Intellectual Property Law Association (AIPLA), Member
South Asian Bar Association, Member
Disclaimer
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.
